Showcasing the Global Regulatory Model
This article was originally published in RAJ Devices
The Global Harmonization Task Force has issued a key document that explains the overall design of the global regulatory model for medical devices that the initiative has been working on since its creation 15 years ago1. The document shows for the first time how the numerous guidance documents the GHTF has issued over the years – together with other important documents – interrelate and intersect and how they relate to the medical device life cycle.
You may also be interested in...
KTE-X19, Kite’s potential new CAR-T therapy, will in the end be fast-tracked at the European Medicines Agency. Lilly failed to secure the speedy review it was seeking for selpercatinib
Priority review is likely in the US for Kite’s second CAR-T therapy offering but it seems the company will have to make do with standard review in the EU.
Hot on the heels of winning EU fast-track review status for belantamab mafodotin, GlaxoSmithKline has asked the European Medicines Agency to grant accelerated assessment to another of its planned marketing applications.